{
    "nct_id": "NCT05769062",
    "official_title": "Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors",
    "inclusion_criteria": "Inclusion Criteria - Prospective Cohort\n\n* Undergoing primary treatment for locally advanced cervical cancer with definitive, curative-intent chemoradiotherapy (chemotherapy must be a radiosensitizing platinum agent).\n* At least 18 years of age.\n* English speaker.\n* Able to understand and willing to sign an IRB approved written informed consent document.\n\nExclusion Criteria - Prospective Cohort\n\n* Received any form of pelvic radiation (excepting diagnostic studies).\n* Currently taking and does not plan to take anti-estrogenic hormonal therapy.\n* Diagnosis of interstitial cystitis/chronic bladder pain, irritable bowel syndrome, or inflammatory bowel disease.\n* Currently being treated for a chronic non-cancer pain condition (treatment for pain after enrollment is acceptable).\n\nInclusion Criteria - Retrospective Cohort (historical control)\n\n* Received primary treatment for locally advanced cervical cancer with definitive, curative-intent chemoradiotherapy (chemotherapy must be a radiosensitizing platinum agent).\n* At least 18 years of age.\n\nExclusion Criteria - Retrospective Cohort (historical control)\n\n* Received any form of pelvic radiation (excepting diagnostic studies).\n* Took anti-estrogenic hormonal therapy during treatment or in the 6 months following treatment.\n* Diagnosis of interstitial cystitis/chronic bladder pain, irritable bowel syndrome, or inflammatory bowel disease at the start of treatment.\n* Simultaneously treated for a chronic non-cancer pain condition at the start of treatment.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}